Sernova Biotherapeutics Inc Stock
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1150 CAD | +4.55% |
|
+4.55% | -11.54% |
| Market Cap | 43.43M 31.16M 26.95M 25.17M 23.09M 2.97B 44.12M 295M 116M 1.49B 117M 114M 4.91B | P/E 2026 * |
-3.83x | P/E 2027 * | -2.88x |
|---|---|---|---|---|---|
| Enterprise Value | 43.43M 31.16M 26.95M 25.17M 23.09M 2.97B 44.12M 295M 116M 1.49B 117M 114M 4.91B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 8.69x |
| Free-Float |
86.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +4.55% | ||
| 1 week | +4.55% | ||
| Current month | +4.55% | ||
| 1 month | -11.54% | ||
| 3 months | -30.30% | ||
| 6 months | -25.81% | ||
| Current year | -11.54% |
| 1 week | 0.1 |  | 0.12 |
| 1 month | 0.1 | | 0.13 |
| Current year | 0.1 | | 0.2 |
| 1 year | 0.1 | | 0.2 |
| 3 years | 0.1 | | 0.91 |
| 5 years | 0.1 | | 2.22 |
| 10 years | 0.1 | | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 12/08/2024 |
James Parsons
DFI | Director of Finance/CFO | 60 | 11/10/2024 |
David Burke
IRC | Investor Relations Contact | - | 11/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
James Parsons
BRD | Director/Board Member | 60 | 19/04/2012 |
Steven Sangha
BRD | Director/Board Member | - | 24/04/2023 |
David Paterson
BRD | Director/Board Member | - | 01/09/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/7/26 | Sell | Company | -115,000 | 0.0305% | ||
| 22/5/26 | Option | Director | 173,418 | 0.0499% | ||
| 27/2/26 | Option | Director | 377,970 | 0.1123% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.55% | +4.55% | -42.50% | -86.93% | 31.16M | |
| +0.47% | +4.09% | -10.21% | +20.08% | 130B | |
| +1.37% | -3.93% | -16.97% | +0.27% | 12.63B | |
| +5.28% | +7.98% | +112.66% | +140.73% | 10.61B | |
| +2.59% | -3.43% | -42.66% | -67.38% | 4.7B | |
| +2.93% | +3.12% | -24.17% | +41.20% | 2.7B | |
| +2.16% | +19.82% | -23.98% | -75.44% | 1.74B | |
| +2.82% | +0.80% | -15.13% | -12.55% | 1.69B | |
| +2.16% | -0.93% | -33.76% | -28.67% | 1.66B | |
| Average | +2.70% | +3.76% | -10.75% | -7.63% | 18.42B | |
| Weighted average by Cap. | +1.01% | +3.66% | -4.44% | +22.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5M 3.59M 3.1M 2.9M 2.66M 341M 5.08M 34M 13.34M 171M 13.47M 13.18M 566M |
| Net income | -12.83M -9.2M -7.96M -7.43M -6.82M -876M -13.03M -87.22M -34.23M -439M -34.56M -33.8M -1.45B | -19.77M -14.19M -12.27M -11.46M -10.51M -1.35B -20.09M -134M -52.77M -677M -53.27M -52.11M -2.24B |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | CA$0.1150 | +4.55% | 209,041 |
| 06/08/26 | CA$0.1100 | 0.00% | 132,500 |
| 05/08/26 | CA$0.1100 | 0.00% | 163,658 |
| 04/08/26 | CA$0.1100 | 0.00% | 276,571 |
| 31/07/26 | CA$0.1100 | 0.00% | 71,610 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1150CAD
Average target price
0.4500CAD
Spread / Average Target
+291.30%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Select your edition
All financial news and data tailored to specific country editions
